Search our Innovation Portfolio

Cardiocity is developing Rhymthpad technology that allows a patient to be screened for Hypertension during an existing 30 second hand placement screening for Atrial Fibrillation. The innovation is to combine the Cardio and Vascular side of the patient assessment simultaneously. It is hoped that more detailed analysis may be performed in a proactive screening session at each Primary Care Interaction. The benefit to the NHS is identifying patients with both AF and Hypertension earlier, allowing for a medication solution to be implemented, rather than waiting for a significant event to occur.

Docobo’s Aegle system, developed in partnership with Crawley, Horsham and West Sussex CCGs, will support proactive programmes in primary care focused on CVD. Aegle integrates ‘pointing’ to patients at risk from existing risk stratification with remote monitoring technology to deliver individual care plans and track patients through screening, assessment and monitoring. It will enable clinicians to manage CVD as a single family and optimise a case finding approach that relies on the specific cardiovascular conditions.